QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Conditions: B-cell Acute Lymphoblastic Leukemia Interventions: Biological: QH103 Cell Injection; Drug: Fludarabine; Drug: Cyclophosphamide Sponsors: Anhui Provincial Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials